Top Factor Driving Pulmonary Embolism Market Growth in 2025: Rising Prevalence Of Blood Clots Fuels Growth In The Pulmonary Embolism Market

How Big Is the Pulmonary Embolism Market Expected to Be, and What Will Its Growth Rate Be?
The pulmonary embolism market has expanded rapidly in recent years. It will grow from $2.03 billion in 2024 to $2.27 billion in 2025, at a CAGR of 11.9%. The growth is due to advancements in anticoagulant therapies, ongoing research and clinical trials, heightened awareness of pulmonary embolism, and developments in VTE prophylaxis.

The pulmonary embolism market is forecasted to grow rapidly, reaching $3.63 billion by 2029, at a CAGR of 12.5%. The market's growth is driven by targeted therapies, telemedicine, remote monitoring, and global health equity initiatives. Key trends include the use of artificial intelligence in diagnosis, novel anticoagulants, the establishment of pulmonary embolism response teams, and patient-centered care.

What Are the Primary Growth Drivers for the Pulmonary Embolism Market?
The growing prevalence of blood clots is anticipated to drive the expansion of the pulmonary embolism market. A blood clot, also known as a thrombus, is a gel-like or semi-solid mass formed within a blood vessel. Blood clots can increase the risk of pulmonary embolism by obstructing blood flow to the lungs. These clots often originate in the deep veins of the legs, leading to a potentially life-threatening blockage. For instance, in April 2022, according to Gavi, the Vaccine Alliance, an international organization focused on improving vaccine access, research indicated a 33-fold increase in potentially fatal lung clots and a fivefold rise in deep vein thrombosis cases within 30 days of COVID-19 exposure. Therefore, the rising occurrence of blood clots is driving the growth of the pulmonary embolism market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13026&type=smp

Who Are the Dominant Companies Influencing Pulmonary Embolism Market Trends?
Major companies operating in the pulmonary embolism market are Pfizer Inc., Johnson and Johnson Private Limited, F. Hoffmann-La Roche Ltd., Merck And Co.Inc., Novartis AG, Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, GSK PLC, Abbott Laboratories, AstraZeneca PLC, Medtronic PLC, Eli Lilly and Company, Gilead Sciences Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Mitsubishi Tanabe Pharma Corporation, Genentech Inc., Hikma Pharmaceuticals PLC, Aspen Pharmacare Holdings Limited, Nippon Shinyaku Co. Ltd., Penumbra Inc., Fresenius Kabi AG, Inari Medical Inc., AngioDynamics Inc., Otsuka Pharmaceutical Co. Ltd.

How Is the Pulmonary Embolism Market Evolving?
Key players in the pulmonary embolism market are actively developing innovative medical devices, such as the Triever16 Curve catheter and the RevCore thrombectomy catheter, to strengthen their competitive position. For instance, in June 2023, Inari Medical Inc., a US-based medical device company, launched the Triever16 Curve catheter and the RevCore thrombectomy catheter. The Triever16 Curve catheter is specifically designed for peripheral thrombectomy and pulmonary embolism treatments. It features exceptional trackability, a pre-shaped curve for targeted aspiration, and a unique structure that facilitates access to larger, more powerful catheters of 20F or 24F. The RevCore thrombectomy catheter, on the other hand, is tailored for treating venous in-stent thrombosis, utilizing a nitinol basket to capture and extract blood clots. These advancements significantly enhance the safety and efficacy of pulmonary embolism procedures.

What Are the Different Segmentations in the Pulmonary Embolism Market?
The pulmonary embolism market covered in this report is segmented -

1) By Treatment: Medications, Mechanical Devices, Other Treatments
2) By Diagnosis: Chest X-Ray, Electrocardiogram (ECG), Magnetic Resonance Imaging (MRI), Computed Tomography Scan, Pulmonary Angiography, Venography, Venous Ultrasound, D-Dimer Test, Other Diagnosis
3) By Symptoms: Shortness Of Breath, Chest Pain, Cough, Irregular Heartbeat, Dizziness, Fever, Cyanosis, Other Symptoms
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:
1) By Medications: Anticoagulants, Thrombolytics
2) By Mechanical Devices: Inferior Vena Cava (IVC) Filters, Catheter-Assisted Thrombectomy
3) By Other Treatments: Surgical Embolectomy, Supportive Care

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/pulmonary-embolism-global-market-report

Which Region Is at the Forefront of the Pulmonary Embolism Market?
North America was the largest region in the pulmonary embolism market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pulmonary embolism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Pulmonary Embolism Global Market Report?

- Market Size Analysis: Analyze the Pulmonary Embolism Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Pulmonary Embolism Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Pulmonary Embolism Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Pulmonary Embolism Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13026

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.